10:05 AM EST - Emerald Health Therapeutics, Inc. : Announced that its Pure Sunfarms joint venture has finalized the expansion of its credit facility with its existing lender to $59 million, including accordion provisions of $22.5 million. The expanded credit facility consists of a $7.5-million revolving operating loan and a $10-million term loan, in addition to its existing $19-million term loan. The New Term Loan is specifically designated for the 1.1 million square foot Delta 2 greenhouse while the Existing Term Loan is specifically designated for the 1.1-million square foot Delta 3 greenhouse facility. Emerald Health Therapeutics, Inc.
shares V.EMH are trading up $0.01 at $0.15.
